Ad is loading...
MENU
ADAP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Adaptimmune Therapeutics (ADAP) Ownership - Who owns Adaptimmune Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
60 Jubilee Avenue
Phone
+44 1235430000
Employees
449
Web
https://www.adaptimmune.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
150.1M
P/E Ratio
N/A
Total Cash
214.79M
Projected Growth
N/A
Total Debt
47.35M
Revenue
141.46M
Risk (Beta)
2.32
Dividend Yield
N/A
Total Cash/Share
0.84
Total Debt/Equity
N/A
Revenue/Share
0.70 USD as % of share price
Fundamentals
ADAP
Capitalization
150M
P/E Ratio
N/A
Risk (Beta)
2.32
Dividend Yield
N/A
Total Cash
215M
Total Cash/Share
0.84
Total Debt
47.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.70%
Revenue
141M
ROE
N/A
Book Value
96.3M
P/B Ratio
1.88
Cash Flow
N/A
Earnings
-0.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.08M
Current Ratio
3.09
Current Revenue Per Employee
285592.44
Dividends Per Share - Security
N/A
EBITDA
-85.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.81
Shares Held By Institutions
154M
Shares Outstanding - Current
256M
Total Liabilities
225M
Total Volume MTD
N/A
Value
1
Gain YTD
-26.028
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of vaccines and cancer immunotherapy products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Jubilee Avenue
Phone
+44 1235430000
Employees
449
Web
https://www.adaptimmune.com